a randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid feverhepatitis a vaccine in healthy adults:一项随机,和三批联合feverhepatitis健康成人伤寒疫苗的免疫反应原性开放标签研究.pdfVIP

a randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid feverhepatitis a vaccine in healthy adults:一项随机,和三批联合feverhepatitis健康成人伤寒疫苗的免疫反应原性开放标签研究.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
a randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid feverhepatitis a vaccine in healthy adults:一项随机,和三批联合feverhepatitis健康成人伤寒疫苗的免疫反应原性开放标签研究

CLINICAL THERAPEUTICS®/VoL.26, No. 7, 2 0 0 4 A Randomized, Open-Label Study of the Immunogenicity and Reactogenicity of Three Lots of a Combined Typhoid Fever/Hepatitis AVaccine in Healthy Adults Micha Loebermann, MD, 1 Herwig Kollaritsch, MD, 2 Tom Ziegler, MD, 1 Pamela Rendi-Wagner, MD, 2 Laurent Chambonneau, MSc, 3 Rafaele Dumas, MD, 3 and Michael Lafrenz, MD 1 ~Department of TropicalMedicine and Infectious Diseases, Faculty of Medicine, University of Rostoch, Germany, 2Department of Specific Prophylaxis and TropicalMedicine, Institute of Pathophysiology, University of Vienna,Austria, and 3AventisPasteur MSD, Lyon, France A B S T R A C T Background: Travelers are often advised to receive both the typhoid fever and hepatitis A virus (HAV) vac- cines, particularly when going to areas where the 2 diseases are endemic. Thus, combined administration of these vaccines could make immunization more acceptable by reducing the number of injections needed. Objective: This study compared the safety profiles and immunogenicity of 3 batches of a combined typhoid fever/HAV vaccine administered using a dual-chamber bypass syringe. Methods: This randomized, open-label study was conducted at 2 university-based travel clinics in Germany and Austria. Subjects received a single IM injection from 1 of 3 batches of the combined vaccine. Blood samples were drawn immediately before and 28 days after vaccination to evaluate the response to the 2 antigens by assessing geometric mean titers (G

您可能关注的文档

文档评论(0)

ajgoaw + 关注
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档